Skip to main content

Table 2 Distribution of the MRSA isolates on the basis of the molecular epidemiological characterization and pattern of resistance to non β-lactam antibiotics

From: Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period

No. of isolates

STa

SCCmec type

No. of isolates

Resistance profileb

MLVFctype

46

22

IVa

10

TET

004

2

CLR TET

004

2

CIP

004

1

CIP TET

004

1

GM TET

004

6

susceptible

004

1

CIP SXT

009

1

CIP CLR ERY

017

1

CIP CLR ERY

019

1

susceptible

024

1

susceptible

043

1

CIP CLR ERY

058

1

CIP

059

1

SXT TET

060

1

CIP ERY

061

1

CIP

068

1

TET

070

IVb

7

CIP CLR ERY

023

5

CIP CLR ERY

073

1

CIP CLR ERY SXT

073

13

8

IVc

2

CIP CLR ERY

006

2

CIP

044

2

CIP CLR ERY

044

1

CIP ERY

012

1

CIP GM RIF

018

1

CIP ERY

035

1

CIP CLR ERY GM

045

1

CIP

064

IVa

1

susceptible

003

1

CIP CLR ERY

045

8

1

IVa

3

CLR ERY TET

065

2

CLR ERY TET

033

1

CLR ERY

010

1

CLR ERY

040

1

CLR TET

049

3

50

IVa

2

susceptible

030

1

susceptible

002

3

398

IVa

1

CLR GM RIF TET

029

1

CIP TET

029

1

GM RIF TET

029

2

1517

IVa

2

CLR

057

  1. a ST, sequence type.
  2. b other than β-lactams.
  3. CLR, clarithromycin; CIP, ciprofloxacin; ERY, erythromycin; GM, gentamicin; RIF, rifampicin; SXT, sulfamethoxazole- trimethoprim; TET, tetracycline.
  4. c MLVF, Multiple-Locus Variable-Number Tandem Repeat Fingerprinting.